| Title： | the consensus for use of intravitreal aflibercept with a Treat-and Extend regimen for management of neovascular age-related macular degeneration in China |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Treatment |
| Countries and regions： | China |
| Guidelines users： | retinal experts |
| Evidence classification method： | not available |
| Development unit： | Shanghai General Hospital |
| Registration time: | 2021-02-05 |
| Registration number： | IPGRP-2021CN031 |
| Purpose of the guideline: |
Latest registration
